Prevalence of founder BRCA1 and BRCA2 mu
โ
Marco Van der Looij; Csilla Szabo; Istvan Besznyak; Gyorgy Liszka; Bela Csokay;
๐
Article
๐
2000
๐
John Wiley and Sons
๐
French
โ 55 KB
๐ 2 views
We have investigated the impact of BRACA1 and BRACA2 mutations that were frequently identified among Hungarian high-risk breast-ovarian cancer families (Ramus et al., 1997b, AJHG), on the development of breast and ovarian cancer in the general Hungarian population. The prevalence of 3 BRCA1 mutation